(Q38864099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Yasunori Fujita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Toshio Kojima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kosuke Mizutani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Taku Kato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Takashi Deguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Masafumi Ito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

12 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

1568-1578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

Microtubule-binding agents: a dynamic field of cancer therapeutics

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

MicroRNAs: novel mediators of resistance to microtubule-targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

RNAi therapeutics and applications of microRNAs in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

TRAIL/Apo-2L: mechanisms and clinical applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Microtubule plus-end tracking proteins SLAIN1/2 and ch-TOG promote axonal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

The multiple faces of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Caspase-8 as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23031

21 January 2018

Identifiers

DOI

10.1002/PROS.23031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26074357%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference